Term: insulin aspart
IPA: ˌɪn.səl.ɪn ˈæ.spɑɹt

==English==
{{wp}}

===Etymology===
From {{af|en|insulin|aspartate|alt2=aspart(ate)}}.

===Pronunciation===
* {{IPA|en|/ˌɪn.səl.ɪn ˈæ.spɑɹt/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} A [[short-acting]] modified [[recombinant]] form of [[insulin]] (a short-acting [[insulin analogue]]) administered by [[subcutaneous]] [[injection]] in the treatment of [[w:type 1 diabetes|type 1]] and {{w|type 2 diabetes}}. Trade names (trademarks) include NovoLog, Fiasp, and others.
#: {{hy